5th Aug 2013 7:00 am |
RNS |
Sativex MS Spasticity Cognition Study Results |
22nd Jul 2013 7:00 am |
RNS |
Files new application to expand Sativex to France |
15th Jul 2013 7:00 am |
RNS |
Notice of Results |
8th Jul 2013 7:00 am |
RNS |
Product Launch |
4th Jul 2013 8:31 am |
RNS |
Holding(s) in Company |
10th Jun 2013 12:53 pm |
RNS |
Director/PDMR Shareholding |
3rd Jun 2013 7:00 am |
RNS |
Second Quarter Financial Results |
30th May 2013 5:30 pm |
RNS |
Exercise of Over-Allotment Option |
14th May 2013 1:00 pm |
RNS |
Notice of Results |
10th May 2013 4:28 pm |
RNS |
Holding(s) in Company |
10th May 2013 4:24 pm |
RNS |
Holding(s) in Company |
9th May 2013 3:40 pm |
RNS |
Total Voting Rights |
8th May 2013 8:00 am |
RNS |
Closing of Initial Public Offering on Nasdaq |
7th May 2013 7:00 am |
RNS |
Sativex Commercialization Approval in Italy |
1st May 2013 5:47 pm |
RNS |
Pricing of U.S. Initial Public Offering |
22nd Apr 2013 7:00 am |
RNS |
US Patent Allowance for SATIVEX Formulation Spray |
18th Apr 2013 2:23 pm |
RNS |
Amendment to Registration Statement for NASDAQ |
12th Apr 2013 10:31 am |
RNS |
Results of General Meeting |
10th Apr 2013 7:00 am |
RNS |
Sativex moved to Schedule 4 of UK Drugs Act |
3rd Apr 2013 7:00 am |
RNS |
New US Patent Allowance for Delivery of SATIVEX |
22nd Mar 2013 2:35 pm |
RNS |
Posting of Shareholder Circular |
19th Mar 2013 2:46 pm |
RNS |
Appoints Stephen Schultz VP of Investor Relations |
19th Mar 2013 1:10 pm |
RNS |
Update on Sativex in Germany |
19th Mar 2013 1:01 pm |
RNS |
Filing for listing on NASDAQ |
19th Feb 2013 3:16 pm |
RNS |
Directorate Change |
19th Feb 2013 9:30 am |
RNS |
Blocklisting Interim Review |
4th Dec 2012 10:04 am |
RNS |
Director/PDMR Shareholding |
30th Nov 2012 2:54 pm |
RNS |
Director/PDMR Shareholding |
30th Nov 2012 2:50 pm |
RNS |
Director/PDMR Shareholding |
28th Nov 2012 7:00 am |
RNS |
Preliminary Results |
28th Nov 2012 7:00 am |
RNS |
PhIIa Study Identifies New Anti-Diabetic Treatment |
22nd Nov 2012 11:31 am |
RNS |
Notice of Results |
12th Nov 2012 7:00 am |
RNS |
GW to Present at Lazard Healthcare Conference |
12th Oct 2012 7:00 am |
RNS |
Positive German Sativex Data Presented at ECTRIMS |
1st Oct 2012 7:00 am |
RNS |
Appointment of Chief Operating Officer |
13th Sep 2012 7:00 am |
RNS |
Publication of New Epilepsy Data |
20th Aug 2012 12:14 pm |
RNS |
Director/PDMR Shareholding |
17th Aug 2012 4:04 pm |
RNS |
Blocklisting Interim Review |
22nd Jun 2012 7:00 am |
RNS |
German GBA establishes positive benefit of Sativex |
13th Jun 2012 10:19 am |
RNS |
Director/PDMR Shareholding |